#NICE #JnJ #Haematology #multiplemyeloma #daratumumab #daratumumabquadruplet #transplanteligiblemyeloma #NICEGuidance #MRDguidedtreatment #NICEFinalDraftGuidance #PERSEUSdata #daratumumabbasedregimen #VRdinduction #MRDguidedapproach #personalisedtreatment #PatientAccess
zurl.co/ZmXyU
zurl.co/ZmXyU
NICE backs daratumumab quadruplet for transplant‑eligible myeloma - PharmaTimes
Guidance supports MRD‑guided treatment approach
pharmatimes.com
September 21, 2026 at 8:54 AM